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Results:
Observations reveal that one of the four groups of patients with CKD (group 3) had more apoptotic CD4 T cells than the other group; this group also had an increased malnutrition inflammation score (MIS), an elevated Kt/V, and a higher incidence of smoking.
Conclusion:
A simple two-parameter-based stratification strategy could be used to design effective immunological therapies that differentiate the degrees of immunosuppression across groups of patients with CKD.
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| INTRODUCTION
Chronic kidney disease (CKD) is the convergent end-point of several pathological processes, 1 being the most prevalent disease for patients with hypertension and diabetes mellitus. 2 Its evolution is insidious and characterized by progressive and irreversible loss of kidney function. 1, 3 As such, there is a linear correlation between loss of nephrons and progressive increase in uremic toxin levels in the blood. 1,3 Therefore, patients with CKD are maintained in a state of residual uremia.
4-6
Individuals with terminal CKD often have anemia, cachexia, and advanced atherosclerotic disease, associated with a persistent state of immuno-suppression that leads to the development of infections, tumors, and lower vaccine response rates. 7, 8 This observed deterioration may be due to a state of prolonged and dysfunctional activation of the innate immune system and the reduction in lymphocyte functional activity, because of chronic exposure to uremic toxins.
8-10
During hemodialysis, contact between antigen presenting cells (APCs) and the dialyzer membrane occur, causing mechanical stress and APCs activation. 5, 11, 12 There is also exposure to other factors, such as oxidized lipoproteins (oxidized LDL), bacterial degradation products (eg, LPS), or nonenzymatic glycosylation of proteins, which may contribute to immune system activation.
11
Chronic activation of APCs induces strong CD4 T-cell activation and differentiation 7, 13 ; however, over a long period, this chronic activation could lead to a reduction in the peripheral CD4 T lymphocyte counts. This reduction could be related to a reduced production of naïve T cells in the thymus, a reduction in lymphocyte proliferative capacity, a decreased production of effector-memory CD4 T cells (TEM), and an increased apoptosis rate. 7, 13 However, it is still to be determined which of these mechanisms contribute to the immunode- 
| MATERIALS AND METHODS
| Patients
The amounts of CKD and control patients, as well as the criteria used for their selection, are described in the Appendix S1. All procedures followed the Helsinki Declaration of 1975, as revised in 2008, and were in accordance with the local laws and regulations (protocol number 65896316.8.0000.5064).
The participants were divided into four groups (Table 1) , according to leukocyte count and the amount of time receiving dialytic therapy.
| FACS staining
Preparation of blood samples before staining is described in the Appendix S1. After RBC removal, cells were re-suspended in FACS buffer (Thermo Fisher Scientific Inc., Waltham, MA, USA) and counted. 
| Clinical data from medical records
The variables used from each patient are described in the Results section. Smoking and erythropoietin use was quantified by assigning indices, for which the values 0 ("non-smoker" or "non-user") or 1 ("smoker" or user) were assigned to each patient. The means and standard errors of these indices were calculated for each group; the closer the index was to the value 1, the higher were the proportions of smokers or erythropoietin users found in each group. score (MIS) is 10.0, the Albumin concentration was 3.7 g/DL, the antiHbsAg concentration (10 mIU/mL), total/corrected calcium concentration (10.2 mg/dL), and body mass index (BMI; 21.8). For parathyroid hormone (PTH), a reference value of 385 pg/mL for patients with CKD was used. The P values < .05 were considered statistically significant.
| Multivariate analysis
| Statistical analysis
| RESULTS
| Variations in leukocyte and CD4 T-cell numbers, and amounts of apoptotic CD4 T cells in CKD patient groups
We observed 11% of patients with CKD have an apoptotic CD4 T-cell count of approximately 200 cells/mm³, which is typical for patients having an acquired immunodeficiency syndrome. 14, 15 Therefore, this parameter may be an indicator for groups of patients with CKD having an impaired immune response.
The patients were divided into 4 groups according to Dialysis Time and Leukocyte Count, as described in Table 1 Figure 1E ), were always higher in group 3; this difference was not observed with respect to percentages of apoptotic CD4 T cells ( Figure 1D ).
| Clinical/hematological data are correlated to patients in different groups of patients with CKD
After finding differences in numbers of apoptotic CD4 T cells among patients with CKD, we evaluated how clinical/hematological data could be used to distinguish the group 3 patients from patients in other groups.
A multivariate correlation analysis of the clinical/hematological data from patients with CKD ( Figure 2 , Table 2 ) was carried out to discover salient factors from each group. In group 1, residual diuresis, hemoglobin, and serum albumin were correlated. The distinguishing factors for group 2 were a history of smoking, serum albumin, antiHbsAg, and Kt/V. The factors found in group 3 were MIS, serum phosphorus, the use of erythropoietin, Kt/V, and intact PTH. Finally, the salient factors found in group 4 were calcium, BMI, intact PTH, hemoglobin levels, and the use of erythropoietin.
| Changes in Kt/V and PTH levels and influence of smoking inside groups of patients with CKD
Kt/V, PTH, and smoker index were the only altered parameters observed in some patients in this study when compared with reference values. Patients in groups 2 and 3 presented Kt/V higher indices than Autovetor: intensity and proximity vector calculated by multivariate analysis; for positive autovectors (groups 3 and 4), the larger an autovector value is, the stronger is its correlation with that group; for negative autovectors (groups 1 and 2), the smaller an autovector value is, the stronger is its correlation with that group.
F I G U R E 3 Changes in Kt/V, PTH, and smoking index in patients with CKD. Levels in Kt/V, PTH, and smoking were measured in patients with CKD and compared with standard values. These patients were divided into 4 groups according to period of hemodialysis (higher or lower than 4 y) and number of leukocytes/mL of blood (higher or lower than 3.0 × 10 6 cells/mL). A, average values of Kt/V; B, average concentration (pg/mL) of parathyroid hormone (PTH) dosage; C, smoking index. The results are representative of 2 independent experiments of repeated measurements, *P < .01 the reference levels of 1.2, indicative of a good dialysis ( Figure 3A) .
PTH levels were lower in patients from group 2 only when compared with the average reference level (385 pg/dL) for patients with CKD ( Figure 3B ). An interesting measurement was the smoker index ( Figure 3C ). Group 3 had the highest number of smokers, and there were no smokers in group 4.
| DISCUSSION
Patients with CKD have widely different degrees of immunosuppression, 7, 8 which in some cases cannot be correlated to the amount of CD4 T cells in their blood 16 but it may be correlated to the quality of these cells. Therefore, their stratification into groups with distinct clinical/hematological characteristics (Figures 2 and 3 ; Table 2 ) could help to elaborate more effective and personalized treatment plans.
We found that patients could be separated according to relatively simple parameters that are easily obtained in lab screening, namely their leukocyte counts, and their time period receiving dialysis therapy (Table 1 ). The group receiving dialysis for a longer time (>4 years) and displaying a lower number of leukocytes (<3.0 × 10 6 leukocytes/mm 3 )
would have a higher immune response impairment than the other 3 groups due to elevated CD4 T-cell apoptosis (Figure 1 ). Thus, patients stratified by these two criteria could receive differentiated treatments according to their "immunological status."
Future studies could perform prospective evaluations of each patient group, taking into consideration the correlation between immuno-suppression and occurrence of infections, neoplasm, and renal transplantation outcomes. Nonetheless, we believe our results are useful to establish a criterion for further studies with CKD patients.
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